Text
Determinan Profitabilitas Perusahaan Farmasi di Indonesia dalam Periode Pre Covid dan Peak Covid
This study aims to analyze the comparison between the factors that affect the profitability of pharmaceutical companies in Indonesia in the pre-covid and peak covid periods. The sample used in this study includes companies in the pharmaceutical sub-sector listed on the Indonesia Stock Exchange in the period January 2016 to December 2020. The study is divided into two periods, namely pre-covid for January 2016 to December 2019 and peak covid for January 2020 to December 2020. The data used in this study is panel data. The study regressed the independent variables of firm size, company efficiency, liquidity, market power, and firm's growth on return on equity, return on assets, and earnings per share. The results showed that firm size had an effect on ROA in the pre-covid period and ROE and ROA in the peak covid period. Company efficiency was found to have an effect on profitability on ROA in the pre-covid period but not at peak covid. Liquidity was also found to have an influence on ROA in the pre-covid period as well as ROE and ROA in the peak covid period. Furthermore, market power has an influence on ROE, ROA, and EPS in the pre-covid period as well as ROE and ROA during the peak covid period. Lastly, firm's growth has an influence on pre-covid EPS and ROA peak covid..Ada Tabel
Ketersediaan
| Call Number | Location | Available |
|---|---|---|
| 13074 | PSB lt.2 - Karya Akhir | 1 |
| Penerbit | Depok: Program Studi Manajemen Fakultas Ekonomi dan Bisnis UI 2021 |
|---|---|
| Edisi | - |
| Subjek | Liquidity Profitability Market power Covid 19 Pharmaceuticals Firm’s Growth |
| ISBN/ISSN | - |
| Klasifikasi | - |
| Deskripsi Fisik | xviii, 102 p. ; diagr. ; 30 cm |
| Info Detail Spesifik | - |
| Other Version/Related | Tidak tersedia versi lain |
| Lampiran Berkas | Tidak Ada Data |